Revelation Biosciences Inc
NASDAQ:REVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revelation Biosciences Inc
NASDAQ:REVB
|
US |
|
Fox Marble Holdings PLC
LSE:FOX
|
UK |
|
U
|
Unimode Overseas Ltd
BSE:512595
|
IN |
|
Rafaella Resources Ltd
ASX:RFR
|
AU |
|
H
|
Honeyfund.com Inc
OTC:HNFD
|
US |
|
NextEd Group Ltd
ASX:NXD
|
AU |
|
B
|
Baru Gold Corp
OTC:BARUF
|
CA |
|
Betonjaya Manunggal Tbk PT
IDX:BTON
|
ID |
|
P
|
Private Rented Sector SA
WSE:PFM
|
PL |
|
N
|
Nauticawt Ltd
SGX:42D
|
SG |
|
S
|
Scient Inc
OTC:SCNTQ
|
US |
|
Exopharm Ltd
ASX:TYP
|
AU |
|
Flux Power Holdings Inc
NASDAQ:FLUX
|
US |
|
I
|
International Petroleum Corp
TSX:IPCO
|
CA |
|
F
|
FG Imperii Acquisition Corp
NASDAQ:FGII
|
US |
|
G
|
GRC International Group PLC
LSE:GRC
|
UK |
|
S
|
Sena J Property PCL
SET:SENAJ
|
TH |
|
Y
|
Yooshin Engineering Corp
KOSDAQ:054930
|
KR |
|
B&P Co Ltd
TSE:7804
|
JP |
|
C
|
Canox Corp
TSE:8076
|
JP |
|
Almawave SpA
MIL:AIW
|
IT |
Bankruptcy Probability
Revelation Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Revelation Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Revelation Biosciences Inc
NASDAQ:REVB
|
4.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
468.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Revelation Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Revelation Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
